眼球后注射康宁克通A治疗Graves眼病的观察  

A study of retrobulbar injected Kenacort A for Graves ophthalmopathy

作　　者：胡燕飞 邓奋刚 莫耀溥 张远健 

机构地区：[1]广州第一人民医院眼科,510180 [2]广州第一人民医院核医学科

出　　处：《眼科》2000年第4期210-211,共2页Ophthalmology in China

摘　　要：目的 :研究球后注射康宁克通A(triamcinoloneacelonide)治疗Graves眼病的疗效和并发症。方法 :对确诊为Graves眼病的 2 5例 3 4只眼 ,用康宁克通A肌肉注射剂 8mg、2 %利多卡因 1ml,按常规操作方法对患眼行球后注射 ,每周 1次共 1 0次。结果 :1 8只眼的临床表现有改善 ,有效率为 52 94 % ;1 6只眼无改善 ,无病情加重及严重并发症出现。结论 :球后注射康宁克通A治疗Graves眼病安全简便有一定疗效。HT5”SS][WT5”BZ][ST5”BZ]Objective:To study the effectiveness and complications of retrobulbar injected Kenacort A(triamcinolone acetonide)for Graves ophthalmopathy.Methods:25 cases (34 eyes)with Graves ophthalmopathy are treated with retrobulbar injected Kenacort A intramuscular 8mg and 2% Lidocaine 1ml.Once per week for 10 times.Results:The clinical manifestations have shown improvements in 18 eyes(52.94%)and unimproved in 16 eyes(47.06%).There is no serious complications.Conclusion:The retrobulbar injected Kenacort A for Gravesophthalmopathy is safe,easy and may be effecive to some patients. [HT5”H][WT5”HZ][ST5”HZ]

关 键 词：格雷夫斯 曲安奈德 治疗 GRAVES眼病 

分 类 号：R771.3[医药卫生—眼科]